scispace - formally typeset
D

Donna M. Rennick

Researcher at Schering-Plough

Publications -  27
Citations -  6916

Donna M. Rennick is an academic researcher from Schering-Plough. The author has contributed to research in topics: Nucleic acid & Interleukin 10. The author has an hindex of 13, co-authored 27 publications receiving 6704 citations. Previous affiliations of Donna M. Rennick include University of California, San Francisco & Merck & Co..

Papers
More filters
Journal ArticleDOI

Requirement for IL-13 Independently of IL-4 in Experimental Asthma

TL;DR: This article showed that IL-4 receptor α chain-dependent pathway may underlie the genetic associations of asthma with both the human 5q31 locus and the IL4 receptor and showed that selective neutralization of IL-13, a cytokine related to interleukin-4 that also binds to the α chain of the IL 4 receptor, ameliorated asthma phenotype.
Journal ArticleDOI

Enterocolitis and colon cancer in interleukin-10 : deficient mice are associated with aberrant cytokine production and cd4+ th1-like responses

TL;DR: The authors characterized the progressive stages of chronic intestinal inflammation that develops spontaneously in specific pathogen-free (SPF) mice with a targeted disruption in the IL-10 gene (IL-10-/-) and showed that inflammatory changes first appear in the cecum, ascending and transverse colon of 3-week-old mutants.
Journal ArticleDOI

Interleukin-10 is a central regulator of the response to LPS in murine models of endotoxic shock and the Shwartzman reaction but not endotoxin tolerance.

TL;DR: Results show that IL-10 is a critical component of the host's natural defense against the development of pathologic responses to LPS although it is not responsible for LPS-induced tolerance.
Journal Article

Requirement for IL-13 independently of IL-4 in experimental asthma

TL;DR: Murine models support participation of interleukin-4 (IL-4) and the IL-4 receptor in asthma and selective neutralization of IL-13 ameliorated the asthma phenotype, including airway hyperresponsiveness, eosinophil recruitment, and mucus overproduction.